Share your experiences and challenges, and get insights from your peers. 

What you need to know about industry consolidation, new PBM transparency rules, the impact of breakthrough medications and new biosimilars, and more.

Gain insights into patient selection, treatment monitoring, and long-term benefits. Discover strategies to optimize outcomes while managing costs.

Genomic testing, new meds and new digital platforms can mean saving patients from cycling through therapies to see what works. Learn what’s new.

It’s not an even playing field – so what are health systems, health plans and drugmakers doing to ensure equitable, affordable access to life-saving drugs?

Weight loss, diabetes improvement and lowered risk for heart disease – what’s not to like?  Managing appropriateness, access and cost are key. 

Federal transparency legislation aimed at pharmacy benefits may have significant implications for plan sponsors. Learn what you need to know now.   

Cost, value and site of care – what strategies work? 

What’s worked for this panel of benefits leaders?